Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of pharmaceuticals targeting cancer and inflammatory diseases. Its structure allows for selective modification to enhance binding affinity with specific enzyme targets. Commonly employed in medicinal chemistry for optimizing drug candidates due to its favorable reactivity and ability to mimic purine motifs in biological systems. Also utilized in research settings to design ATP-competitive inhibitors for protein kinases involved in signal transduction pathways.